GGrantIndex
Sort

64,565 grants matching drug discovery

Core B: University of Kentucky Alzheimer's Disease Core Center

$975,595
Gregory A Jicha · University Of Kentucky · P30 · FY2022 · AG

Novel modulators of the dopamine transporter for alcohol and nicotine use disorders

$975,562
John M Littleton · Naprogenix, Inc · R44 · FY2021 · AA

"Discovery and Development of Anti-Diabetic Drugs."

$975,307
Gerard M Housey · Housey Pharmaceutical Research Lab · R44 · FY2012 · DK

The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)

$975,197
Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2021 · MH

Illuminating transcriptional condensates using an integrated approach

$975,000
Liling Wan · University Of Pennsylvania · DP2 · FY2024 · HG

Optimization and Characterization of "MYC Degraders" for Pediatric Medulloblastoma

$975,000
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2020 · NS

Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases

$974,853
Jay L Rothstein · Immunext, Inc. · R44 · FY2022 · AI

Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases

$974,850
Joel S. Bader · Johns Hopkins University · U01 · FY2018 · CA

Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery

$974,700
Bharath Takulapalli · Spoc Proteomics Inc. · R44 · FY2022 · TR

A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention

$974,572
Raymond Joseph Terryn · Genetic Networks, Llc · R44 · FY2020 · TR

Metabolic Networks and Pathways in Alzheimer's Disease

$974,544
Rima F Kaddurah-Daouk · Duke University · R01 · FY2014 · AG

Hepatic Clearance Chip for Pharmacokinetics

$974,458
Murat Cirit · Javelin Biotech · R44 · FY2024 · TR

SBIR Phase II: Innovative Protein Microarrays

$974,421
Andrzej K Drukier · Biotraces Inc · · FY2004 · TIP

Molecular Biomarkers for Malaria

$974,388
Dyann F Wirth · Harvard School Of Public Health · R56 · FY2009 · AI

Lead optimization of novel ML-IAP antagonists to treat lung cancer

$974,339
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA

Lead optimization of novel ML-IAP antagonists to treat lung cancer

$974,339
Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA

Genetic Determinants of Epilepsy in Murine Systems

$974,220
Wayne N. Frankel · Columbia University Health Sciences · R01 · FY2021 · NS

Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis

$973,917
Ashkan Vaziri · Biosensics, Llc · R44 · FY2025 · NS

Drug Development for Prostate Cancer and other Metastatic Processes

$973,508
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Tissue Processing-Sequencing Facility

$973,474
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias

$973,322
Mark W Albers · Massachusetts General Hospital · R01 · FY2024 · AG

PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA NIDA REF. NO. N01DA-22-8959. BASE AWARD.

$973,245
Matthew Walentiny · Virginia Commonwealth University · N01 · FY2022 · DA

Parallelized Imaging and Automated Analysis of Zebrafish Assays with a Gigapixel Microscope

$973,119
Mark Harfouche · Ramona Optics, Inc. · R44 · FY2022 · OD

Development of novel research tools and a database for mapping human mitochondrial tRNA modifications by mass spectrometry

$973,114
Nigel Lawrence Webb · Ribonova, Inc. · R44 · FY2017 · DA

An integrative omics approach to investigate gene-environment interaction in colorectal cancer risk

$973,110
Ulrike Peters · Fred Hutchinson Cancer Center · R01 · FY2023 · CA